Health-tech startup Cobionix has secured U.S. $3 million in funding to accelerate the commercialization of its flagship autonomous medical robot, CODI®, in North American and UK healthcare systems.
Co-founded in 2021 by Waterloo Engineering alumni Nima Zamani and Dr. Tim Lasswell (both BASc ‘14 and MASc ‘16, mechanical and mechatronics engineering) with John Van Leeuwen (BSc ‘81), Cobionix builds autonomous AI-driven solutions to help make health care more accessible.
The funding round was led by venture capital firm TitletownTech which specializes in digital health, agriculture, manufacturing, logistics and entertainment.
“Our relationship with TitletownTech started when they recognized the potential of our platform to help address shortcomings in the health sector while giving providers more time with patients,” said Zamani, CTO of Cobionix.
Pilot programs are already underway in Canada, the United States, and the United Kingdom, including collaborations with the Saskatchewan Health Authority and the National Health Service (NHS). The new funding will support further clinical validation and facilitate the launch of CODI® into U.S. healthcare markets.
CODI® is a configurable, collaborative robot designed to carry out patient-facing medical procedures such as diagnostic ultrasound. Its unique architecture allows for rapid tool changes and over-the-air software updates, enabling healthcare providers to adapt CODI® to a variety of clinical applications without costly hardware modifications.
Go to Automating routine health care tasks through robotics takes another decisive step forward for the full story.